Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jubilant Pharmova is scheduled to meet institutional investors in one-on-one/group meetings in Mumbai from August 13-14, 2026. The discussions will cover the Q1 FY27 earnings presentation, which will be filed on August 10, 2026, after the financial results disclosure.
Aug 05 2026 16:57:09
Jubilant Pharmova Ltd - 530019 - Newspaper Advertisements Titled ''Notice Of 48Th Annual General Meeting, E-Voting, Record Date And Final Dividend Information
Jubilant Pharmova's Board has recommended a final dividend of Rs.5 per equity share for FY26. The record date for the dividend is July 24, 2026, pending shareholder approval at the upcoming AGM.
Aug 02 2026 23:04:17
Jubilant Pharmova Ltd - 530019 - Intimation To Shareholders About Deduction Of Tax At Source (TDS) On Final Dividend For FY 2025-26, If Approved By The Members At The Ensuing AGM
Jubilant Pharmova has informed shareholders about the procedures for tax deduction at source (TDS) on the recommended final dividend of Re.1 per equity share for FY 2025-26. Shareholders must submit necessary documents by August 14, 2026, to avail beneficial tax rates.
Aug 01 2026 22:56:07
Jubilant Pharmova Ltd - 530019 - Board Meeting Intimation for Intimation Of Board Meeting Scheduled For August 07, 2026
Jubilant Pharmova's Board of Directors will meet on August 07, 2026, to consider the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. This meeting is in compliance with SEBI Listing Regulations.
Jul 30 2026 17:45:06
Jubilant Pharmova Ltd - 530019 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Jubilant Pharmova shareholders to vote on re-appointment of Mr. Priyavrat Bhartia as MD and Mr. Arjun Shanker Bhartia as Jt. MD for three years until May 2029. The e-voting window runs from July 19 to August 17, 2026.
Jul 18 2026 19:33:20
Read More